These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24761657)

  • 21. [Exploration of quality control of inorganic elements in Chinese herbal medicines for stimulating blood circulation and relaxing muscles and joints by atomic absorption spectrophotometry].
    Zhang QF; Fan MM; Wang GM; Tu LF; Wang C
    Guang Pu Xue Yu Guang Pu Fen Xi; 2007 Dec; 27(12):2595-7. PubMed ID: 18330319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
    Kim EJ; Chen Y; Huang JQ; Li KM; Razmovski-Naumovski V; Poon J; Chan K; Roufogalis BD; McLachlan AJ; Mo SL; Yang D; Yao M; Liu Z; Liu J; Li GQ
    J Ethnopharmacol; 2013 Mar; 146(1):40-61. PubMed ID: 23286904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspective of chemical fingerprinting of Chinese herbs.
    Liang YZ; Xie PS; Chan K
    Planta Med; 2010 Dec; 76(17):1997-2003. PubMed ID: 21064007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Special influence of molecular imprinting technology on traditional Chinese medicine theories].
    Xia ZS; He FY; Deng KW; Liu WL; Shi JL; Tang Y
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1266-70. PubMed ID: 23944049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Patented technology status quo and development trend for Chinese herbal medicines].
    Li C; Huang L
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1468-72. PubMed ID: 19771885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A strategy for evaluating antipyretic efficacy of Chinese herbal medicines based on UV spectra fingerprints.
    Ni LJ; Zhang LG; Hou J; Shi WZ; Guo ML
    J Ethnopharmacol; 2009 Jul; 124(1):79-86. PubMed ID: 19527822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Status and thinking of supervision and management of Chinese herbal medicine].
    Xie XY
    Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1832-5. PubMed ID: 24010306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research strategy and practice of "multi-dimensional structure and process dynamics quality control system" of traditional Chinese medicines].
    Zhang MH; Gu JF; Feng L; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(21):3608-12. PubMed ID: 24494540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pyrrolizidine alkaloids-containing Chinese medicines in the Chinese pharmacopoeia and related safety concerns].
    Tang J; Hattori M
    Yao Xue Xue Bao; 2011 Jul; 46(7):762-72. PubMed ID: 22010344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of the contents of trace elements in chinese herbal medicines for treating respiratory system diseases].
    Han LQ; Dong SF; Liu JH
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Feb; 28(2):453-5. PubMed ID: 18479045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Separation and molecular identification of fungal contamination on surface of 15 Chinese herbal medicines].
    Wang WL; Xu H; Chen HZ; Zheng RS; Tan J; Zhan RT; Chen WW
    Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(12):1910-4. PubMed ID: 24066582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of the quality evaluation of traditional Chinese herbal medicines using chromatography of fingerprints].
    Li X; Wang Y; Ma L; Cui J; Hong W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Feb; 29(1):192-6. PubMed ID: 22404037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of reference extracts in quality control of traditional Chinese medicines].
    Lu TL; Zhai WM; Cai BC; Zhou Y; Mao CQ; Li L
    Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(3):462-5. PubMed ID: 23668030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multi-dimensional structure quality control technology system of Danmu injection based on component structural theory].
    Yin R; Zhu FX; Li XF; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(21):3632-7. PubMed ID: 24494545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of adverse reactions from contaminants in Chinese herbal medicines can be minimized by using quality products and qualified practitioners.
    Hohmann N; Koffler K
    Int J Environ Health Res; 2002 Mar; 12(1):99-100; author reply 101. PubMed ID: 11970820
    [No Abstract]   [Full Text] [Related]  

  • 36. Chromatographic separation techniques and data handling methods for herbal fingerprints: a review.
    Tistaert C; Dejaegher B; Vander Heyden Y
    Anal Chim Acta; 2011 Apr; 690(2):148-61. PubMed ID: 21435470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica.
    Xie PS; Leung AY
    J Chromatogr A; 2009 Mar; 1216(11):1933-40. PubMed ID: 18757061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer.
    Qi F; Li A; Inagaki Y; Gao J; Li J; Kokudo N; Li XK; Tang W
    Biosci Trends; 2010 Dec; 4(6):297-307. PubMed ID: 21248427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unique issue in the standardization of Chinese materia medica: processing.
    Zhao Z; Liang Z; Chan K; Lu G; Lee EL; Chen H; Li L
    Planta Med; 2010 Dec; 76(17):1975-86. PubMed ID: 21049396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on dosage form design for improving oral bioavailability of traditional Chinese medicines].
    Xia HJ; Zhang ZH; Yao DD; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2911-6. PubMed ID: 24380323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.